01 4Zyrtec
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 97
2018 Revenue in Millions : 110
Growth (%) : -12
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 91
2019 Revenue in Millions : 108
Growth (%) : -16
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 91
2020 Revenue in Millions : 91
Growth (%) : 11
Main Therapeutic Indication : Anti-Allergic
Currency : USD
2018 Revenue in Millions : 114
2017 Revenue in Millions : 116
Growth (%) : -2%
LOOKING FOR A SUPPLIER?